Earnings Miss: Angi Inc. Missed EPS By 38% And Analysts Are Revising Their Forecasts

It's been a sad week for Angi Inc. (NASDAQ:ANGI), who've watched their investment drop 14% to US$11.35 in the week since the company reported its quarterly result. It looks like a pretty bad result, all things considered. Although revenues of US$266m were in line with analyst predictions, statutory earnings fell badly short, missing estimates by 38% to hit US$0.23 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.NasdaqGS:ANGI Earnings and Revenue Growth November 7th 2025 Taking into account the latest results, the most recent consensus for Angi from eight analysts is for revenues of US$1.08b in 2026. If met, it would imply a credible 2.5% increase on its revenue over the past 12 months. Per-share earnings are expected to surge 63% to US$1.33. Before this earnings report, the analysts had been forecasting revenues of US$1.09b and earnings per share (EPS) of US$1.53 in 2026. The analysts seem to have become more bearish following the latest results. While there were no changes to revenue forecasts, there was a substantial drop in EPS estimates. View our latest analysis for Angi The consensus price target held steady at US$22.38, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values Angi at US$32.00 per share, while the most bearish prices it at US$18.00. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business. These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Angi's past performance and to peers in the same industry. It's also worth noting that the years of declining revenue look to have come to an end, with the forecast stauing flat to the end of 2026. Historically, Angi's top line has shrunk approximately 7.6% annually over the past five years. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 12% annually. So it's pretty clear that, although revenues are improving, Angi is still expected to grow slower than the industry. The Bottom Line The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Angi's revenue is expected to perform worse than the wider industry. The consensus price target held steady at US$22.38, with the latest estimates not enough to have an impact on their price targets. With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Angi analysts - going out to 2027, and you can see them free on our platform here. You can also see whether Angi is carrying too much debt, and whether its balance sheet is healthy, for free on our platform here.